logo

Last Update

This profile was last updated on 7/17/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Andrew Griffiths?

Andrew Griffiths

Scientific Founder

BioMillenia

Email: a***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

BioMillenia

France

Company Description

BIOMILLENIA, a France-based privately held company, is a leading technology solution provider for the development of novel green chemistry products. BIOMILLENIA's disruptive BIOMILLENIA DIMENSION 300X platform, based on licensed technology that was developed b...more

Background Information

Employment History

Director

Louis Pasteur University - France


Expert In Droplet Biochemistry

Medical Research Center


Affiliations

Plasticell Ltd

Scientific Advisory Board Member


RainDance Technologies Inc

Founder


Education

Ph.D.


PhD

Molecular Biology

University of Leicester


Web References(35 Total References)


Team | BioMillenia

biomillenia.com [cached]

Prof. Andrew Griffiths
Andrew Griffiths is a Professor of Biochemistry at École Supérieure de Chimie Industrielles de Paris (ESPCI) in Paris and formerly the holder of a Chaire d'Excellence from the Ministère pour la Recherche, France, at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg. Andrew is a founder of RainDance Technologies.


Scientific Advisory Board - Plasticell

www.plasticell.co.uk [cached]

Prof Andrew Griffiths
Professor Griffiths is Director of the Laboratory of Biological Chemistry at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS), Université Louis Pasteur, Strasbourg, France. He is a leading expert in combinatorial biology methods, being an inventor on over 19 MRC patents on antibody phage display, and the co-inventor of the in vitro compartmentalization (IVC) method of directed protein evolution on which he currently works. Professor Griffiths was previously a group leader at the MRC Laboratory of Molecular Biology, Cambridge, and holds a PhD in Molecular Biology from the University of Leicester.


HiFiBiO: High Fidelity Biology | Your Partners In Antibody Biodiscovery

hifibio.com [cached]

Prof. Andrew Griffiths
Andrew Griffiths is a Professor of Biochemistry at École Supérieure de Chimie Industrielles de Paris (ESPCI) in Paris. more Prof Griffiths is formerly the holder of a Chaire d'Excellence from the Ministère pour la Recherche, France, at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg. After receiving a B.Sc. in Biochemistry (First Class) from the University of Sheffield in 1985 and a Ph.D. from the University of Leicester, in 1988, he joined Greg Winter at the MRC Laboratory of Molecular Biology (LMB), Cambridge where he co-developed phage-display for the selection of human antibodies for therapy, first as a Post Doc. (1989-1990) and later as a Cancer Research Campaign Fellow (1991-1995). This work led directly to the creation of two companies, Cambridge Antibody Technology (acquired by AstraZeneca for $1.32 billion) and Domantis (acquired by GSK for $0.45 billion), and several blockbuster drugs including Humira® and Benlysta®. His current work is in the development of droplet-based microfluidic systems for directed evolution of enzymes, high-throuhgput screening for drug discovery, and diagnostic applications. Andrew is a founder of RainDance Technologies.


HiFiBiO: High Fidelity Biology | Your Partners In Antibody Biodiscovery

hifibio.com [cached]

Prof. Andrew Griffiths
Andrew Griffiths is a Professor of Biochemistry at École Supérieure de Chimie Industrielles de Paris (ESPCI) in Paris. more Prof Griffiths is formerly the holder of a Chaire d'Excellence from the Ministère pour la Recherche, France, at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS) in Strasbourg. After receiving a B.Sc. in Biochemistry (First Class) from the University of Sheffield in 1985 and a Ph.D. from the University of Leicester, in 1988, he joined Greg Winter at the MRC Laboratory of Molecular Biology (LMB), Cambridge where he co-developed phage-display for the selection of human antibodies for therapy, first as a Post Doc. (1989-1990) and later as a Cancer Research Campaign Fellow (1991-1995). This work led directly to the creation of two companies, Cambridge Antibody Technology (acquired by AstraZeneca for $1.32 billion) and Domantis (acquired by GSK for $0.45 billion), and several blockbuster drugs including Humira® and Benlysta®. His current work is in the development of droplet-based microfluidic systems for directed evolution of enzymes, high-throuhgput screening for drug discovery, and diagnostic applications. Andrew is a founder of RainDance Technologies.


Plasticell – Scientific Advisory Board

www.plasticell.co.uk [cached]

Prof Andrew Griffiths
Professor Griffiths is Director of the Laboratory of Biological Chemistry at the Institut de Science et d'Ingénierie Supramoléculaires (ISIS), Université Louis Pasteur, Strasbourg, France. He is a leading expert in combinatorial biology methods, being an inventor on over 19 MRC patents on antibody phage display, and the co-inventor of the in vitro compartmentalization (IVC) method of directed protein evolution on which he currently works. Professor Griffiths was previously a group leader at the MRC Laboratory of Molecular Biology, Cambridge, and holds a PhD in Molecular Biology from the University of Leicester.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory